Different laboratories have investigated the impact of deficiencies in AhR in intestinal cancers using colon cancer models that are driven by colonic inflammation and tumor promotion downstream of chemical insults, pathogen infections [10,118,125], or high-fat diets [116]. This evidence concerns the gene AHR and neoplasm.